International Assets Investment Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
SO
PAM
SW
PFSRSONJ
AI
CUAMC
CWS
International Assets Investment Management's CHRS Position: Q2 2026 in Review
International Assets Investment Management increased its Coherus Oncology (CHRS) stake by 1.3% in Q2 2026, buying an estimated $898 and bringing the position to 42,958 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.
International Assets Investment Management first reported a position in CHRS in Q3 2023 and has held it in 11 quarters since. The position peaked at $142K in Q4 2023. 27 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.
- International Assets Investment Management held 42,958 shares of Coherus Oncology worth $61.9K as of Q2 2026.
- International Assets Investment Management bought 550 Coherus Oncology shares in Q2 2026, an estimated $898.
- Coherus Oncology made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1245 holding.
- International Assets Investment Management first reported a position in Coherus Oncology in Q3 2023 and has held it in 11 quarters since.
- International Assets Investment Management's Coherus Oncology position peaked at $142K in Q4 2023.
- 27 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.
Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.